Edition:
United States

Probi AB (PROB.ST)

PROB.ST on Stockholm Stock Exchange

337.50SEK
12 Dec 2017
Change (% chg)

17.00kr (+5.30%)
Prev Close
320.50kr
Open
346.00kr
Day's High
353.00kr
Day's Low
333.50kr
Volume
28,612
Avg. Vol
24,757
52-wk High
613.00kr
52-wk Low
290.00kr

Chart for

About

Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi... (more)
No analyst recommendations are available for .

Overall

Beta: 0.48
Market Cap(Mil.): kr3,731.94
Shares Outstanding(Mil.): 11.64
Dividend: 1.00
Yield (%): 0.31

Financials

  Industry Sector
P/E (TTM): -- 21.82 15.71
EPS (TTM): -- -- --
ROI: -- 12.49 31.93
ROE: -- 15.66 16.16

BRIEF-Probi Signs Agreement For Product Launch In North America

* SIGNED MAJOR AGREEMENT FOR LAUNCH OF FUNCTIONAL FOOD PRODUCT IN NORTH AMERICA

Dec 12 2017

BRIEF-Probi Q3 operating profit down at SEK 16.6‍​ million

* Q3 NET SALES SEK ‍​133.5 MILLION VERSUS SEK 89.2 MILLION YEAR AGO

Oct 25 2017

BRIEF-Probi: Q2 net sales at SEK 172 million

* Q2 2017: PROBI COMPLETES INTEGRATION AND ENDS FIRST HALF OF 2017 WITH INCREASE IN SALES AND EARNINGS

Jul 19 2017

Earnings vs. Estimates